Bromocriptine: A sympatholytic, D2-dopamine agonist for the treatment of type 2 diabetes (Diabetes Care (2011) 34, (789-794))

Resultado de la investigación: Comment/debate › revisión exhaustiva

ASJC Scopus subject areas

@article{c3270ed1b3cf46f3a8ee716122adf3a0,

title = "Bromocriptine: A sympatholytic, D2-dopamine agonist for the treatment of type 2 diabetes (Diabetes Care (2011) 34, (789-794))",

author = "DeFronzo, {R. A.}",

year = "2011",

month = jun,

doi = "10.2337/dc11-er06",

language = "English (US)",

volume = "34",

pages = "1442",

journal = "Diabetes Care",

issn = "1935-5548",

publisher = "American Diabetes Association Inc.",

number = "6",

}

TY - JOUR

T1 - Bromocriptine

T2 - A sympatholytic, D2-dopamine agonist for the treatment of type 2 diabetes (Diabetes Care (2011) 34, (789-794))

AU - DeFronzo, R. A.

PY - 2011/6

Y1 - 2011/6

UR - http://www.scopus.com/inward/record.url?scp=80052010890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052010890&partnerID=8YFLogxK

U2 - 10.2337/dc11-er06

DO - 10.2337/dc11-er06

M3 - Comment/debate

AN - SCOPUS:80052010890

SN - 1935-5548

VL - 34

SP - 1442

JO - Diabetes Care

JF - Diabetes Care

IS - 6

ER -